Outreach Signals
Publishing Details
Contact & Outreach
About This Podcast
Explore Statistics
Recent Episodes
S4E5 Joel Gallant: Where Will Antiretroviral Therapy Go Next?
After years of relatively little movement on the HIV treatment front, we're entering a new period of activity, as fresh FDA drug approvals begin to roll in and the research pipeline grows more…
S4E4 Demetre Daskalakis: Great HIV Care Is a Form of Resistance
Demetre Daskalakis, M.D., M.P.H., has returned to his roots: He's the new chief medical officer in town at Callen-Lorde, a widely respected, LGBTQ-centric HIV and health care institution in New York…
S4E3 Jeanne Marrazzo: "We Just Can't Stop"
Newly appointed IDSA CEO (and former NIAID Director) Jeanne Marrazzo, M.D., M.P.H., joins us this month to discuss a wealth of important topics that stand at the intersection of HIV research,…
S4E2 "What Matters to You?" How Oni Blackstock Practices Hope
We welcome Oni Blackstock, M.D., M.H.S., to our miniseries of interviews with people who are leading some of the big conversations we're having as a health care community during a time of great…
S4E1 Back to Basics
Regardless of your specific role in HIV care, you are almost certainly feeling the deeply challenging moment we face as science-respecting, empathetic human beings. But even as the U.S. response to…
S3E12 Top HIV Clinical Developments of 2025
Each year on TheBodyPro, David Alain Wohl, M.D., of the University of North Carolina summarizes and analyzes the 10 new studies and noteworthy events that he feels are most likely to have a palpable…
You Can't Spell AIDS Without AI
Whether we think about it with excitement or fear (or both), AI has become a part of our daily lives — and, increasingly, it's a force we need to consider in HIV care provision. How can we best adapt…
Antiretroviral Therapy Is Not a Rotisserie Chicken
This month, we're slicing up a feast of guidance and information on HIV treatment switching in the setting of viral suppression. ART, after all, is not a "set it and forget it" proposition: Even when…
S3E9 We Hear, They Heal
This month, we're talking about an infrequently discussed, but quite powerful, implement we have in our clinical toolkit for optimizing patient outcomes: our ears. HIV/sexual health physician,…
S3E8 A Weighty Conundrum Concluded (and Other IAS 2025 Highlights)
This month, we're taking stock of clinically noteworthy developments from the IAS Conference on HIV Science in July. On the docket: new (definitive?) data on the relationship between weight gain and…
S3E7 HIV Guidelines Under Threat
This month, we're diving in deep on the U.S. approval of lenacapavir for PrEP -- both the promise it offers in expanding HIV prevention options and the current uncertainty around access, both in the…
S3E6 Wonderful Bad News
This month, we're digging into some recent, clinically notable HIV research in the U.S. that leaves us seeing a complex mix of clouds and silver (or perhaps gold?) linings. Specifically: new findings…
S3E5 Can the British Be Our HIV Backup?
In a time of growing uncertainty for the HIV response within the U.S., you may be wondering: What do I do if the public guidelines and resources I rely on to provide HIV-related clinical services…
S3E4 In HIV Care, the Nuances Matter
Myles Helfand and Laura Waters, M.D., FRCP, discuss recently published, clinically noteworthy findings from a trio of venerable HIV cohort studies. First, they review new data from the ATHENA study…
Not Your Everyday HIV Conference
Laura Waters, M.D., and Myles Helfand recap several noteworthy moments and clinically important studies from this year's Conference on Retroviruses and Opportunistic Infections (CROI 2025), which…
S3E2 Our New, Sudden HIV Care Crisis
Myles Helfand is joined by new co-host and expert HIV clinician-researcher Laura Waters, M.D., to dig into an issue they had once hoped they would never need to spend a podcast episode discussing:…
S3E1 How Will HIV Care Evolve in 2025?
You can't truly look to the future without taking time to make sense of the past. That's why our January episode explores some of the most important studies and events of 2024 from an HIV clinical…
S2E12 GLP-1 Agonists and HIV: Do Weight-Loss Drugs Make Sense for Your Patients?
GLP-1 Agonists and HIV: Do Weight-Loss Drugs Make Sense for Your Patients? Three GLP-1 agonist drugs (which originally had been confined to diabetes treatment) are currently FDA approved specifically…
S2E11 What Clinicians Need to Know—And Do—About HIV Criminalization
For all too many people living with HIV in the U.S., the prospect of facing incarceration because of their status is not an abstraction: It is a real and present danger. And in many states, it has…
S2E10 Vaccination Season
Summer weather is transitioning into sweater weather in most of the U.S., and that means we -- and our patients -- are about to spend a lot more time indoors, inevitably getting exposed to numerous…
Frequently Asked Questions
The Future of HIV Care has published 41 episodes since January 2022, covering topics in Health & Fitness, Medicine.
The Future of HIV Care is currently highly active with new episodes monthly. Average episode length is 40m.
Sign up on Grep.FM to access contact details for The Future of HIV Care, including email and social media links.
Similar Podcasts
Sawbones: A Marital Tour of Misguided Medicine
Justin McElroy, Dr. Sydnee McElroy
584 episodes
The Dr. Hyman Show
Dr. Mark Hyman
1,147 episodes
The Peter Attia Drive
Peter Attia, MD
442 episodes
The Exam Room by the Physicians Committee
Physicians Committee
767 episodes
Dhru Purohit Show
Dhru Purohit
493 episodes
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
500 episodes